• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Cosmetic
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Cosmetic
  • Oligos
✕
  • Home
  • News
  • Expert views
  • Needle-to-needle’: Manufacturing NeoAntigen peptides

Needle-to-needle’: Manufacturing NeoAntigen peptides

28 February 2019
Expert views

Trishul Shah of PolyPeptide Laboratories looks at the prospects for individualised peptide therapeutics* […]

Trishul Shah, Director Business Development,

Speciality Chemicals Magazine, Feb. 2019

Read more

Back to news

Related posts

13 November 2024

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand

Read more
23 October 2024

PolyPeptide supports landmark publication on sustainable peptide synthesis

Read more
9 August 2024

Research article: Sustainable PFAS-free alternatives for TFA in SPPS

Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers